Astellas Pharma Inc. Share Price OTC Markets
Stocks
ALPMY
US04623U1025
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
01:29:59 22/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 15.04 USD | +0.53% |
|
+2.17% | +13.17% |
| 17/08 | CLSA Starts Astellas Pharma at Accumulate with 3,000 Yen Price Target | MT |
| 10/08 | AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge | RE |
| Market Cap | 4,28000Cr 2.69TCr 2.31TCr 2.16TCr 1.98TCr 3.71TCr 2,57600Cr 3.76TCr 25TCr 9.94TCr 1,29400Cr 10TCr 9.89TCr | P/E 2027 * |
11.6x | P/E 2028 * | 12.3x |
|---|---|---|---|---|---|
| Enterprise Value | 4,23800Cr 2.67TCr 2.28TCr 2.14TCr 1.96TCr 3.67TCr 2,55100Cr 3.72TCr 25TCr 9.84TCr 1,28100Cr 10TCr 9.79TCr | EV / Sales 2027 * |
1.83x | EV / Sales 2028 * | 1.8x |
| Free-Float |
98.88% | Yield 2027 * |
3.36% | Yield 2028 * | 3.47% |
Last Transcript: Astellas Pharma Inc.
| 1 day | +0.53% | ||
| 1 week | +2.17% | ||
| Current month | +9.54% | ||
| 1 month | +10.59% | ||
| 3 months | +4.23% | ||
| 6 months | -5.59% | ||
| Current year | +13.17% |
| 1 week | 14.26 |  | 15.18 |
| 1 month | 13.04 | | 15.18 |
| Current year | 12.82 | | 17.35 |
| 1 year | 10.03 | | 17.35 |
| 3 years | 8.37 | | 17.35 |
| 5 years | 8.37 | | 18.18 |
| 10 years | 8.37 | | 18.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 10/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 01/11/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 10/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 63 | 01/06/2019 |
| Director/Board Member | 58 | 01/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.53% | +2.17% | - | - | 2.73TCr | |
| +0.88% | +6.38% | +76.86% | +128.23% | 1,10900Cr | |
| +1.07% | +3.80% | +51.03% | +61.48% | 64TCr | |
| +1.20% | +6.21% | +26.47% | +76.45% | 46TCr | |
| +1.02% | +5.77% | +43.09% | +47.70% | 37TCr | |
| +0.85% | +4.07% | +23.88% | +41.58% | 30TCr | |
| +1.26% | +6.81% | +1.59% | +14.67% | 26TCr | |
| +1.88% | +5.81% | +48.54% | +68.52% | 23TCr | |
| +1.59% | +2.09% | -15.52% | -52.29% | 20TCr | |
| +1.87% | +5.61% | +25.81% | +92.42% | 18TCr | |
| Average | +1.22% | +4.10% | +31.31% | +53.20% | 41.79TCr | |
| Weighted average by Cap. | +1.13% | +4.47% | +44.34% | +72.58% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,31500Cr 1.46TCr 1.25TCr 1.17TCr 1.07TCr 2.01TCr 1,39400Cr 2.03TCr 14TCr 5.38TCr 70TCr 5.47TCr 5.35TCr | 2,13700Cr 1.34TCr 1.15TCr 1.08TCr 986.02Cr 1.85TCr 1,28600Cr 1.87TCr 13TCr 4.96TCr 65TCr 5.05TCr 4.94TCr |
| Net income | 36TCr 223.83Cr 191.73Cr 179.4Cr 164.22Cr 308.19Cr 21TCr 312.26Cr 2.12TCr 826.55Cr 11TCr 840.45Cr 822.17Cr | 33TCr 209.19Cr 179.19Cr 167.66Cr 153.48Cr 288.03Cr 20TCr 291.84Cr 1.98TCr 772.49Cr 10TCr 785.48Cr 768.39Cr |
| Net Debt | -4.19TCr -26Cr -23Cr -21Cr -19Cr -36Cr -2.52TCr -37Cr -249.42Cr -97Cr -1.27TCr -99Cr -97Cr | -44TCr -276.19Cr -236.58Cr -221.37Cr -202.63Cr -380.29Cr -26TCr -385.31Cr -2.62TCr -1.02TCr -13TCr -1.04TCr -1.01TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | $15.04 | +0.53% | 96,845 |
| 20/26/20 | $14.96 | -0.99% | 1,85,962 |
| 19/26/19 | $15.11 | +4.79% | 1,78,364 |
| 18/26/18 | $14.42 | +0.63% | 83,689 |
| 17/26/17 | $14.33 | -2.65% | 92,840 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
- ALPMY Stock
Select your edition
All financial news and data tailored to specific country editions
